GSK-3 Inhibitor IX (BIO)

Kinase Assays

Kinase activities were assayed in Buffer A or C (unless otherwise stated), at 30°C, at a final ATP concentration of 15 μM. Blank values were subtracted and activities calculated as pmoles of phosphate incorporated during a 10 min. incubation. The activities are usually expressed in % of the maximal activity, i.e. in the absence of inhibitors. Controls were performed with appropriate dilutions of dimethylsulfoxide. In a few cases phosphorylation of the substrate was assessed by autoradiography after SDS-PAGE. GSK-3α/β was purified from porcine brain by affinity chromatography on immobilized axin [S1]. It was assayed, following a 1/100 dilution in 1 mg BSA/ml 10 mM DTT, with 5 μl 40 μM GS-1 peptide, a specific GSK-3 substrate, (YRRAAVPPSPSLSRHSSPHQSpEDEEE, synthesized by the Peptide Synthesis Unit, Institute of Biomolecular Sciences, University of Southampton, U.K.), in buffer A, in the presence of 15 μM [γ-32P] ATP (3,000 Ci/mmol; 1 mCi/ml) in a final volume of 30 μl. After 30 min. incubation at 30°C, 25 μl aliquots of supernatant were spotted onto 2.5 x 3 cm pieces of Whatman P81 phosphocellulose paper, and, 20 sec. later, the filters were washed five times (for at least 5 min. each time) in a solution of 10 ml phosphoric acid/liter of water. The wet filters were counted in the presence of 1 ml ACS (Amersham) scintillation fluid.

Cell lines

Cos-1 cells, SH-SY5Y cells, adult rat mammalian cardiomyocytes

Preparation method

The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

5, 10 μM for 24 hr; or 1 μM for 12 hr; 5 μM for 48 hr

Applications

The selective GSK-3 inhibitor BIO inhibited β-catenin phosphorylation on GSK-3-specific sites in Cos-1 cells. Moreover, BIO dramatically decreased level of tyrosine phosphorylation of both GSK-3 isoforms [1]. BIO also increased the proliferation potential of mammalian cardiomyocytes [2].

Animal models

Xenopus laevis embryos model

Dosage form

5, 15 and 50 μM

Applications

BIO is an effective and specific inhibitor of GSK-3 activity in vivo and BIO activated the maternal Wnt signaling pathway in Xenopus laevis embryos [1].

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

1. Meijer, L., Skaltsounis, A. L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S. M., Pearl, L. and Greengard, P. (2003) GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol. 10, 1255-12662.

2. Tseng, A. S., Engel, F. B. and Keating, M. T. (2006) The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol. 13, 957-963